ArticleBritish journal of haematology2023

CAR-T cell therapy is superior to standard of care as second-line therapy for large B-cell lymphoma: A systematic review and meta-analysis.

Liat Shargian et al.PubMed ↗Publisher ↗

No numbers read from the abstract.